Welcome to Medivizor!

You're browsing our sample library. Feel free to continue browsing. You can also sign up for free to receive medical information specific to your situation.

Posted by on Apr 26, 2020 in Hypertension | 0 comments

In a nutshell

This study investigated if catheter-based renal denervation (CB-RD) can be used to lower blood pressure (BP) in patients not taking any medication for lowering BP.

They found that CB-RD reduces BP in patients not taking medications. 

Some background

Hypertension or high blood pressure (BP) is a common condition. Managing BP levels is very important. Uncontrolled BP can lead to serious adverse events. These include heart attack and stroke. There are many ways to manage hypertension. Lifestyle adjustments can help lower BP. Antihypertensive (AHT) drugs can also manage BP. Another option is renal denervation (RD).

RD involves reducing the nerve supply to certain blood vessels in the kidney. These nerves control the volume of urine released from the kidneys. This also affects the amount of blood in the vessels. After RD there may be lower blood volume. This then reduces BP. Some studies suggest that RD is effective in combination with AHTs. It is unclear if RD alone can manage BP levels. 

Methods & findings

This study included 331 patients with uncontrolled hypertension. Patients were randomly assigned to RD or a sham procedure. RD was performed using a catheter-based (CB-RD) method. The catheter is used to place an electrode near the renal nerve. An electrical pulse is used to reduce the nerve signal. Patients in the sham group had a catheter placed but no RD was performed. The main outcome was BP reduction. 

BP reductions were significantly greater in the CB-RD group compared to sham. This was seen 3 months after the procedure. No major safety events were reported after the procedure. 

The bottom line

The authors concluded that CB-RD reduces BP in patients not taking AHT medications.

The fine print

BP reductions without AHT medication were only measured at 3 months. The long-term effect of CB-RD alone is unclear. More studies are needed. 

What’s next?

If you have any concerns regarding hypertension management please consult with your doctor. 

Published By :

Lancet (London, England)

Date :

Mar 30, 2020

Original Title :

Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial.

click here to get personalized updates